MD Mednax PE ratio, current and historical analysis

?
Relative Growth: Rel. Growth: 72
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 96
Relative Profitability: Rel. Profitability: 83

The current price-to-earnings ratio for Mednax stock as of Jun 22, 2026 is 11.25. This is calculated based on the current EPS of $2.09 and the stock price of $23.52 per share. The P/E ratio has increased by 11% from the past four quarters average of 10.2.

MD PE ratio history

How has MD's PE ratio performed in the past

The average historical PE ratio of Mednax for the last ten years is 15.14. The current PE ratio of 11.25 is 26% below the historical average. In the past ten years, MD's PE ratio was at its highest in the Mar 2019 quarter at 30.19, when the stock price was $27.17 and the EPS was $0.9. The lowest value was in the Sep 2025 quarter, when it reached 8.68 with a price of $16.75 and an EPS of $1.93.

Today
11.42
Average
15.14
Median
15.27
Minimum
8.68
Maximum
30.19

Mednax PE ratio by year

Maximum annual increase: 17.14% in 2013

Maximum annual decrease: -27.34% in 2018

Year PE ratio PE change Price EPS
2025 10.86 N/A $21.39 $1.97
2024 N/A N/A $13.12 -$1.19
2023 N/A N/A $9.3 -$0.73
2022 18.81 6.45% $14.86 $0.79
2021 17.67 N/A $27.21 $1.54
2020 N/A N/A $24.54 -$9.44
2019 N/A N/A $27.79 -$18.44
2018 11.19 -27.34% $33 $2.95
2017 15.4 -18.69% $53.44 $3.47
2016 18.94 -4.58% $66.66 $3.52
2015 19.85 -3.31% $71.66 $3.61
2014 20.53 8.85% $66.11 $3.22
2013 18.86 17.14% $53.38 $2.83
2012 16.1 1.96% $39.76 $2.47
2011 15.79 1.87% $36.01 $2.28

Mednax PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2026 10.23 -5.8% $21.39 $2.09
Dec 2025 10.86 25.12% $21.39 $1.97
Sep 2025 8.68 -20.73% $16.75 $1.93
Jun 2025 10.95 N/A $14.35 $1.31
Mar 2025 N/A N/A $14.49 -$0.99
Dec 2024 N/A N/A $13.12 -$1.19
Sep 2024 N/A N/A $11.59 -$3.07
Jun 2024 N/A N/A $7.55 -$3.04
Mar 2024 N/A N/A $10.03 -$0.86
Dec 2023 N/A N/A $9.3 -$0.73
Sep 2023 11.35 -1.73% $12.71 $1.12
Jun 2023 11.55 -6.25% $14.21 $1.23
Mar 2023 12.32 -34.5% $14.91 $1.21
Dec 2022 18.81 105.13% $14.86 $0.79
Sep 2022 9.17 -38.04% $16.51 $1.8

MD Price vs fair value

How does MD's price compare to its estimated fair value based on its growth

MD average PE ratio chart

What is the average PE ratio of MD for the past years

The current PE ratio of MD is greater than its 3-year historical average, but it is lower than the 5 and 10-year averages.

3-year avg
10.6
5-year avg
12.66
10-year avg
15.14
15-year avg
16.5

PE comparison

With a P/E of 11.25, MD stands below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 24.1, Mednax's P/E is 53% lower.

MD PE vs peers

What is MD's PE ratio compared to its peers

MD's PE ratio is higher than its peer stocks THC and UHS.

Stock name PE ratio Market cap
CYH Community Health Systems Inc 0.89 $434.02M
UHS Universal Health Services Inc 6.01 $8.83B
THC Tenet Healthcare Corp 9.33 $15.58B
MD Mednax Inc 11.42 $1.96B

Frequently asked questions

What is Mednax's PE ratio?

The price to earnings ratio for MD stock as of Jun 22, 2026, stands at 11.25.

What is the 3-year average PE ratio for Mednax (MD)?

The 3-year average PE ratio for MD stock is 10.6.

What is the 5-year average PE ratio for Mednax (MD)?

The 5-year average PE ratio for MD stock is 12.66.

What is the highest PE ratio for MD?

The highest quarterly PE ratio in the last ten years has been 30.19 and it was in the Mar 2019 quarter.

How does the current PE ratio for MD compare to its historical average?

The current price to earnings ratio of MD is 26% lower than the 10-year historical average.

How is MD's PE ratio calculated (Mednax PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Mednax's stock price is $23.52. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.09. Therefore, Mednax's P/E ratio for today is 11.25. PE RATIO(11.25) = STOCK PRICE($23.52) / TTM EPS($2.09)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.